Dawei Lian

Fuzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Anjiang formula inhibits PVN microglial activation and lowers blood pressure by targeting RhoA/ROCK2 pathway: a retrospective clinical and experimental study.

Anjiang formula inhibits PVN microglial activation and lowers blood pressure by targeting RhoA/ROCK2 pathway: a retrospective clinical and experimental study.

Journal: Frontiers in pharmacology

Published: January 24, 2026

Integrative network pharmacology and experimental study of Qingda granule in hypertension-induced endothelial dysfunction.

Integrative network pharmacology and experimental study of Qingda granule in hypertension-induced endothelial dysfunction.

Journal: Experimental animals

Published: October 29, 2025

Therapeutic potential of wogonoside in hypertension-induced cardiac injury: Targeting apoptosis and MAPK signaling pathway.

Therapeutic potential of wogonoside in hypertension-induced cardiac injury: Targeting apoptosis and MAPK signaling pathway.

Journal: The Journal of nutritional biochemistry

Published: October 28, 2025

Liensinine can improve vascular remodeling in hypertension through the ferroptosis-related TLR4 inflammatory pathway.

Liensinine can improve vascular remodeling in hypertension through the ferroptosis-related TLR4 inflammatory pathway.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: September 03, 2025

Wet tissue adhesive hydrogel toughened by wheat gluten.

Wet tissue adhesive hydrogel toughened by wheat gluten.

Journal: International journal of biological macromolecules

Published: June 04, 2025

Nelumbinis Plumula attenuates high-fat-induced inflammation in non-alcoholic fatty liver through the NOX/NF-κB pathway.

Nelumbinis Plumula attenuates high-fat-induced inflammation in non-alcoholic fatty liver through the NOX/NF-κB pathway.

Journal: Journal of ethnopharmacology

Published: May 14, 2025

Trifolin inhibits the calcium-driven contraction pathway in vascular smooth muscle.

Trifolin inhibits the calcium-driven contraction pathway in vascular smooth muscle.

Journal: Frontiers in pharmacology

Published: February 09, 2025

Isoliensinine promotes vasorelaxation and inhibits constriction by regulating the calcium channel in hypertension: In vitro and in vivo approaches.

Isoliensinine promotes vasorelaxation and inhibits constriction by regulating the calcium channel in hypertension: In vitro and in vivo approaches.

Journal: European journal of pharmacology

Published: February 04, 2025

Neferine attenuates hypertensive cardiomyocyte apoptosis and modulates key signaling pathways: An in vivo and in vitro study.

Neferine attenuates hypertensive cardiomyocyte apoptosis and modulates key signaling pathways: An in vivo and in vitro study.

Journal: European journal of pharmacology

Published: November 12, 2024

Effects and mechanisms of trifolin on attenuating hypertension-induced vascular smooth muscle cell proliferation and collagen deposition in vivo and in vitro.

Effects and mechanisms of trifolin on attenuating hypertension-induced vascular smooth muscle cell proliferation and collagen deposition in vivo and in vitro.

Journal: Scientific reports

Published: October 18, 2024

Protective mechanisms of Qingda granule in hypertensive kidney injury: Focus on ERK/RSK1-mediated mitochondrial protection.

Protective mechanisms of Qingda granule in hypertensive kidney injury: Focus on ERK/RSK1-mediated mitochondrial protection.

Journal: Chinese journal of natural medicines

Published: September 25, 2024

Trifolin attenuates hypertension-mediated cardiac injury by inhibiting cardiomyocyte apoptosis: Mechanistic insights and therapeutic potential.

Trifolin attenuates hypertension-mediated cardiac injury by inhibiting cardiomyocyte apoptosis: Mechanistic insights and therapeutic potential.

Journal: European journal of pharmacology

Published: July 10, 2024

Showing 1-12 of 16

Last Updated: 09/26/2026